Denali Therapeutics Inc. (DNLI) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Denali Therapeutics Inc. (DNLI) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

DNLI Income Statement

Denali Therapeutics Inc. (DNLI) annual income statement — 11-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	3.6M	0	0	0	0	0	0	0	0	0	0	1.27M	294.12M	35.14M	10.28M	3.56M	52.48M	42.14M	12.51M	5.29M
Revenue Growth %	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	-64.4%	460.45%	-16.61%	-17.83%	-32.66%	128.78%	431.88%	-96.05%	-43.73%
Cost of Goods Sold	0	2.85M	2.87M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-2.85M	-2.87M	0	0	0	0	0	0	0	0	1.27M	294.12M	35.14M	10.28M	3.56M	52.48M	42.14M	12.51M	5.29M
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	100%	100%	100%	100%	100%	100%	100%	100%	100%
Gross Profit Growth %	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	-64.4%	460.45%	-16.61%	-17.83%	-32.66%	128.78%	431.88%	-96.05%	-43.73%
Operating Expenses	134.15M	134.51M	134.5M	137.43M	134.96M	145.58M	129.85M	123.19M	116.59M	117.72M	132.57M	115.06M	123.64M	155.96M	115.63M	111.05M	113.9M	108.64M	89.64M	90.88M
OpEx % of Revenue	3722.11%	-	-	-	-	-	-	-	-	-	-	9081.45%	42.04%	443.8%	1124.45%	3120.12%	217.03%	257.8%	716.28%	1719.55%
Selling, General & Admin	36.28M	30.67M	36.59M	35.48M	32.27M	29.35M	30.06M	24.95M	25.19M	25.24M	24.77M	25.32M	26.12M	27.14M	23.52M	23.26M	21.16M	22.54M	21.76M	19.32M
SG&A % of Revenue	1006.74%	-	-	-	-	-	-	-	-	-	-	1998.82%	8.88%	77.23%	228.69%	653.53%	40.32%	53.49%	173.88%	365.54%
Research & Development	97.02M	103.85M	97.91M	101.95M	102.7M	116.23M	99.79M	98.24M	91.4M	107.02M	107.8M	89.74M	97.52M	128.82M	92.11M	87.79M	92.74M	86.1M	67.88M	71.56M
R&D % of Revenue	2691.98%	-	-	-	-	-	-	-	-	-	-	7082.64%	33.16%	366.57%	895.76%	2466.59%	176.71%	204.31%	542.4%	1354%
Other Operating Expenses	843K	0	0	0	0	0	0	0	0	-1000K	0	0	0	0	0	0	0	0	0	0
Operating Income	-130.54M	-137.36M	-137.37M	-137.43M	-134.96M	-145.58M	-129.85M	-123.19M	-116.59M	-117.72M	-132.57M	-113.8M	170.48M	-120.81M	-105.34M	-107.49M	-61.42M	-66.5M	-77.12M	-85.59M
Operating Margin %	-3622.11%	-	-	-	-	-	-	-	-	-	-	-8981.45%	57.96%	-343.8%	-1024.45%	-3020.12%	-117.03%	-157.8%	-616.28%	-1619.55%
Operating Income Growth %	3.28%	5.65%	-5.79%	-11.57%	-15.76%	-23.67%	2.06%	-8.25%	-168.39%	2.57%	-25.85%	-5.87%	377.59%	-81.68%	-36.6%	-25.58%	0.65%	6.63%	-131.6%	-42.38%
EBITDA	-130.54M	-134.51M	-133.58M	-133.57M	-131.01M	-142.37M	-127.23M	-120.92M	-114.65M	-115.55M	-130.4M	-111.58M	172.77M	-110.77M	-101.25M	-105.34M	-59.34M	-64.42M	-75.03M	-83.41M
EBITDA Margin %	-3622.11%	-	-	-	-	-	-	-	-	-	-	-8806.47%	58.74%	-315.21%	-984.66%	-2959.96%	-113.08%	-152.87%	-599.54%	-1578.16%
EBITDA Growth %	0.36%	5.52%	-5%	-10.46%	-14.27%	-23.21%	2.43%	-8.37%	-166.36%	-4.32%	-28.78%	-5.92%	391.13%	-71.95%	-34.96%	-26.3%	0.45%	6.79%	-130.47%	-43.9%
D&A (Non-Cash Add-back)	0	2.85M	3.78M	3.86M	3.96M	3.21M	2.62M	2.27M	1.94M	2.16M	2.18M	2.22M	2.29M	10.05M	4.09M	2.14M	2.07M	2.08M	2.09M	2.19M
EBIT	0	-128.45M	-128.45M	-126.9M	-124.12M	-132.97M	-114.69M	-107.19M	-99.03M	-132.25M	-132.57M	-113.8M	170.48M	-120.81M	-105.34M	-107.49M	-61.42M	-66.5M	-77.12M	-85.59M
Net Interest Income	0	8.91M	8.92M	10.53M	10.84M	12.61M	15.16M	15.99M	17.57M	15.91M	13.13M	14.44M	12.9M	11.03M	6.66M	4.19M	2.65M	1.28M	1.28M	1M
Interest Income	0	8.91M	8.92M	10.53M	10.84M	12.61M	15.16M	15.99M	17.57M	15.91M	13.13M	14.44M	12.9M	11.03M	6.66M	4.19M	2.65M	1.28M	1.28M	1M
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	2.99M	8.91M	8.92M	10.53M	10.84M	12.61M	15.16M	15.99M	17.57M	15.91M	13.13M	14.44M	12.9M	11.03M	6.66M	4.19M	2.65M	1.28M	1.28M	1M
Pretax Income	-127.55M	-128.45M	-128.45M	-126.9M	-124.12M	-132.97M	-114.69M	-107.19M	-99.03M	-101.8M	-119.44M	-99.35M	183.38M	-109.78M	-98.68M	-103.3M	-58.77M	-65.22M	-75.84M	-84.59M
Pretax Margin %	-3539.21%	-	-	-	-	-	-	-	-	-	-	-7841.59%	62.35%	-312.4%	-959.68%	-2902.47%	-111.98%	-154.77%	-606.01%	-1600.53%
Income Tax	0	0	102K	0	0	0	68K	0	0	0	30K	0	0	0	-6K	0	27K	0	-575K	0
Effective Tax Rate %	0%	0%	-0.08%	0%	0%	0%	-0.06%	0%	0%	0%	-0.03%	0%	0%	0%	0.01%	0%	-0.05%	0%	0.76%	0%
Net Income	-127.55M	-128.45M	-128.55M	-126.9M	-124.12M	-132.97M	-114.75M	-107.19M	-99.03M	-101.8M	-119.47M	-99.35M	183.38M	-109.78M	-98.68M	-103.3M	-58.79M	-65.22M	-75.26M	-84.59M
Net Margin %	-3539.21%	-	-	-	-	-	-	-	-	-	-	-7841.59%	62.35%	-312.4%	-959.62%	-2902.47%	-112.03%	-154.77%	-601.41%	-1600.53%
Net Income Growth %	-2.77%	3.4%	-12.02%	-18.39%	-25.34%	-30.62%	3.95%	-7.89%	-154%	7.27%	-21.07%	3.82%	411.91%	-68.32%	-31.11%	-22.12%	3.13%	6.88%	-130.73%	-45.27%
Net Income (Continuing)	-127.55M	-128.45M	-128.55M	-126.9M	-124.12M	-132.97M	-114.75M	-107.19M	-99.03M	-101.8M	-119.47M	-99.35M	183.38M	-109.78M	-98.68M	-103.3M	-58.79M	-65.22M	-75.26M	-84.59M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.68	-0.69	-0.73	-0.74	-0.72	-0.78	-0.67	-0.63	-0.59	-0.68	-0.86	-0.72	1.30	-0.80	-0.74	-0.84	-0.48	-0.52	-0.62	-0.69
EPS Growth %	5.56%	11.54%	-8.96%	-17.46%	-22.03%	-14.71%	22.09%	12.5%	-145.38%	15%	-16.22%	14.29%	370.83%	-53.85%	-19.35%	-21.74%	2.04%	10.34%	-132.46%	-27.78%
EPS (Basic)	-0.68	-0.69	-0.73	-0.74	-0.72	-0.78	-0.67	-0.63	-0.59	-0.68	-0.86	-0.72	1.34	-0.80	-0.74	-0.84	-0.48	-0.52	-0.62	-0.69
Diluted Shares Outstanding	187.31M	186.64M	175.46M	172.42M	171.45M	171.22M	170.09M	169.46M	168.83M	149.4M	138.25M	137.64M	140.93M	136.52M	132.88M	123.47M	123.01M	122.67M	122.16M	121.74M
Basic Shares Outstanding	187.31M	186.64M	175.46M	172.42M	171.45M	171.22M	170.09M	169.46M	168.83M	149.4M	138.25M	137.64M	137.05M	136.52M	132.88M	123.47M	122.49M	122.67M	122.16M	121.74M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-